This protocol is judged by an institutional critique board, an impartial team that assessments any scientific trials involving humans. If a study entails a Program I drug, as soon as the board approves the protocol as ethical, the scientists should make an application for an investigational new drug (IND) number from the FDA.Clients documented mino